Dexcom (NSDQ:DXCM) said today that its G6 continuous glucose monitoring system will be covered for Medicare beneficiaries.
The company’s product won coverage as a therapeutic CGM system, making it available to beneficiaries who closely manage their insulin dosing.
Get the full story at our sister site, Drug Delivery Business News.